CAS: 1353644-70-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Theliatinib REF: IN-DA01FY3JCAS: 1353644-70-8 | 98% | To inquire | Tue 07 Jan 25 |
 | Theliatinib REF: TM-T7322CAS: 1353644-70-8 | 99.67% | 52.00 €~757.00 € | Mon 13 Jan 25 |
 | Theliatinib (HMPL-309) REF: 3D-DEC64470CAS: 1353644-70-8 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: IN-DA01FY3J
| 10mg | 489.00 € | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Theliatinib
CAS:1353644-70-8
Theliatinib: potent, selective EGFR inhibitor, anti-tumor; Ki=0.05 nM (EGFR), IC50=3 nM (EGFR), 22 nM (T790M/L858R).
Formula:
C25H26N6O2
Purity:
99.67%
Color and Shape:
Solid
Molecular weight:
442.51
Ref: TM-T7322
| 1mg | 52.00 € | ||
| 5mg | 142.00 € | ||
| 10mg | 222.00 € | ||
| 25mg | 368.00 € | ||
| 50mg | 553.00 € | ||
| 100mg | 757.00 € | ||
| 1mL*10mM (DMSO) | 156.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Theliatinib (HMPL-309)
CAS:1353644-70-8
Theliatinib is a drug that has been shown to inhibit the growth of cancer cells …
Formula:
C25H26N6O2
Purity:
Min. 95%
Molecular weight:
442.51 g/mol
Ref: 3D-DEC64470
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
